Talman Group's Capital Connect Launches with True Terpenes Allocating Up to €2.5M for European Expansion
Found this article helpful?
Share it with your network and spread the knowledge!

The Talman Group has launched its Capital Connect service, a platform designed to connect investors and strategic buyers with European cannabis companies seeking capital. The service debuted with its first investor client, True Terpenes, a global leader in terpene science and aroma innovation, which has earmarked up to €2.5 million for investments, equity-linked partnerships, and acquisitions that support its European expansion and overall operations. The launch was announced live in London at the November 9 Talman House event at The Savoy.
Talman's Capital Connect gives family offices, private equity firms, venture funds, and corporate buyers a direct line into The Talman Group and International Cannabis Business Conference's European cannabis networks. Each investor client sets out its capital allocation and investment criteria. Talman then uses its networks and marketing channels to issue a public or private call for pitch decks, filters applicants based on criteria fit, and connects the appropriate candidates. Some applicants are provided the opportunity to pitch at Talman House investor events.
"Investors regularly come to us with capital to deploy and specific companies they want to find," said Alex Rogers, CEO of The Talman Group and ICBC. "We created the Capital Connect service to formalize and streamline this offering. Clients access our European and broader global networks to identify and reach the businesses that fit their objectives. We perform both public and private calls for pitch decks and term sheets, depending on our clients' preference. We are grateful that True Terpenes chose to use our service publicly as a concrete starting point. We look forward to working with Dan Cook. He's a visionary CEO and a strong leader."
True Terpenes is seeking profitable, high-growth companies across two strategic lanes: Reach Builders, companies with established European distribution, strong customer relationships, or GMP production capability that can bring proven products to EU or UK markets; and Bolt-on Innovators, B2B companies with complementary technologies, formulations, or expertise that expand True Terpenes' portfolio into new product categories or customer segments. Ideal candidates demonstrate double-digit revenue growth and at least €1 million in trailing-12-month EBITDA. Companies with defensible IP or GMP certifications may qualify under more flexible financial terms. Potential deal structures include minority equity, convertible investment, commercial partnerships with an equity component, joint ventures, and full acquisition. Capital may be deployed into a single company or across multiple transactions.
"Europe represents a critical growth frontier for compliant cannabis and consumer products," said Dan Cook, CEO of True Terpenes. "I have watched Alex and the Talman team build a trusted network across the European cannabis market. Partnering with Talman gives us a focused, disciplined way to connect with operators who can expand our distribution, strengthen local production, or bring complementary innovation into our portfolio."
Applications open November 19, 2026 at https://thetalmangroup.com/capitalconnect/trueterpenes and will be reviewed on a rolling basis. The Talman Group will conduct initial screening against True Terpenes' criteria; however, True Terpenes retains sole discretion over candidate selection, conducts its own due diligence, and requires True Terpenes' Board approval for any transaction. Submitting an application does not guarantee funding or partnership, and this announcement does not constitute a formal offer to invest.
Operating companies, family offices, funds, and corporate buyers who want to utilize the Talman Capital Connect service can reach The Talman Group directly. Investors may also apply for Talman House membership at thetalmangroup.com. True Terpenes, which has set the standard for sensory, safety, and compliant formulations for ten years, uses its formulations and flavors in over $8 billion in global CPG annually across 107 countries. More information is available at trueterpenes.com.
